Case Report (n=1)
No
Clinicians should consider ticagrelor as a potential reversible cause of QT prolongation and torsades de pointes following myocardial infarction once acute ischemia, electrolyte imbalances, and other offending drugs have been excluded.
Answers are grounded in this paper and cite their sources.
May prompt ticagrelor consideration in unexplained post-MI torsades; single case leaves open causality and generalizability.
We report a case of excessive QT prolongation and subsequent torsades de pointes (TdP) following the administration of ticagrelor in a 58-year-old male patient. The patient had no suspected cause of QT prolongation. After cessation of ticagrelor, QT interval was normalized and no further TdP was observed.
No takes yet. Share an insight, caveat, or question.
Bu et al. (2022) conducted a case report in Myocardial infarction complicated by QT prolongation and torsades de pointes (n=1). Ticagrelor was evaluated on Resolution of QT prolongation and cessation of torsades de pointes.
Synapse has enriched 10 related papers. Consider them for comparative context: